Top Industry News

AstraZeneca has announced plans to invest $2 billion to expand its manufacturing footprint in Maryland. This includes an expansion of its flagship biologics manufacturing facility in Frederick and construction of a new facility in…

Celltrion Group, an Incheon, South Korea-based bio/pharmaceutical company, has announced plans to invest KRW 700 billion ($478 million) to expand a former Lilly active pharmaceutical ingredient (API) manufacturing facility in the US. Celltrion completed the acquisition of…

The US government has released the negotiated drug prices for a second slate of drugs—15 drugs in all–under the Medicare Drug Price Negotiation Program, which was authorized under the Inflation Reduction Act,…

The latest from CDMOs, CMOs, and suppliers featuring Thermo Fisher Scentific, Excelsior, Microsize, AGC Biologics/Atum, Piramal Pharma Solutions, Rentschler Biopharma/Coriolis Pharma, Vetter, WuXi Biologics, Cellares, Cencor, and Sudpack.   Chemicals/Chemical API Manufacturing * Excelsior Raises $95 M For Small-Molecule Mfg Research * Microsize To Acquire Micronization Facility from Lonza * Piramal…

A roundup of news from Daiichi Sankyo/Pfizer’s Seagen, AbbVie/Bio Med X, and Tanabe Pharma. Highlights below.   Patent News * Daiichi Sanyko Wins Favorable Court Ruling in ADC Patent Dispute with Pfizer’s Seagen Partnering News * AbbVie, Bio Med X in Neuroscience…

Novartis has announced plans to expand its operations in North Carolina by creating a new manufacturing hub with drug-substance and drug-product capabilities. The investment is part of the company’s previously…

Regeneron Pharmaceuticals, a Tarrytown, New York-based bio/pharmaceutical company, has announced plans to invest $2 billion for a new manufacturing facility in Saratoga Springs, New York.   The company plans to use…

CSL has announced plans to expand its US presence over the next five years (as reported on November 18, 2025) resulting in approximately $1.5 billion in US capital investments. These…

Merck & Co. has agreed to acquire Cidara Therapeutics, a San Diego, California-based clinical-stage bio/pharmaceutical company developing drug-Fc conjugate therapeutics, for $9.2 billion.  Cidara is using its proprietary Cloudbreak platform…

The latest from CDMOs, CMOs, and suppliers featuring Thermo Fisher Scientific, Avantor, BioDuro, Gattefossé, Nanoform, and Pace Life Sciences. Biologics Manufacturing* Thermo Fisher Scientific Opens Advanced Therapies Collaboration CenterFormulation Development/Drug…